PTPN5 and Alzheimer disease: Our study is aimed at determining a possible contribution of age-related STEP46 and STEP61 expression and activity alterations to the development of AMD using senescence-accelerated OXYS rats that spontaneously develop a phenotype similar to human age-related disorders including AD-like pathology and AMD-like retinopathy.